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Allergy is an exacerbated response of the immune system against non-self-proteins called
allergens and is typically characterized by biased type-2 T helper cell and deleterious IgE
mediated immune responses.The allergic cascade starts with the recognition of allergens
by antigen presenting cells, mainly dendritic cells (DCs), leading toTh2 polarization, switch-
ing to IgE production by B cells, culminating in mast cell sensitization and triggering. DCs
have been demonstrated to play a crucial role in orchestrating allergic diseases. Using differ-
ent C-type lectin receptors DCs are able to recognize and internalize a number of allergens
from diverse sources leading to sensitization. Furthermore, there is increasing evidence
highlighting the role of epithelial cells in triggering and modulating immune responses to
allergens. As well as providing a physical barrier, epithelial cells can interact with allergens
and influence DCs behavior through the release of a number of Th2 promoting cytokines.
In this review we will summarize current understanding of how allergens are recognized by
DCs and epithelial cells and what are the consequences of such interaction in the context
of allergic sensitization and downstream events leading to allergic inflammation. Better
understanding of the molecular mechanisms of allergen recognition and associated signal-
ing pathways could enable developing more effective therapeutic strategies that target the
initial steps of allergic sensitization hence hindering development or progression of allergic
diseases.
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INTRODUCTION
Asthma is a chronic disease of the lung characterized by inflam-
mation and airway hyper-responsiveness. Allergic asthma is prob-
ably the most common form of asthma and is classified as a
type-I hypersensitivity reaction. Most pathologies that are asso-
ciated with allergic asthma are the consequence of an exacerbated
immune response to specific proteins known as allergens in genet-
ically susceptible individuals (1, 2). An allergic reaction is char-
acterized by the synthesis of allergen-specific immunoglobulin
of the IgE class and Th2 cytokines (e.g., IL-4, IL-5, and IL-13),
which lead to recruitment and sensitization of effector cells such
as eosinophils, basophils, and mast cells (1, 3). During allergen
re-exposure, the crosslinking of IgE molecules bounded to high-
affinity Fcε receptors (FcεR) on the surface of mast cells and
basophils results in an immediate release of the soluble mediators,
Abbreviations: AEC, airway epithelial cell; APC, antigen presenting cell; CLR, C-
type lectin receptor; CRD, carbohydrate recognition domain; DC, dendritic cell;
DC-SIGN, dendritic cell-specific intracellular adhesion molecule 3-grabbing non-
integrin; FcεR, Fcε receptor; GM-CSF, granulocyte macrophage colony-stimulating
factor; HDM, house dust mite; IDO, indoleamine 2,3 dioxygenase; LPS, lipopolysac-
charide; MR, mannose receptor; NF-κB, nuclear factor κB; PAMP, pathogen-
associated molecular pattern; PAR, protease activated receptor, PRR, pattern recog-
nition receptor; TGF-β, transforming growth factor-β; TLR, toll-like receptor;
TNF, tumor necrosis factor; TSLP, thymic stromal lymphopoietin; VEGF, vascular
endothelial growth factor.
such as histamine, leukotriene, and prostaglandins, which are
responsible for the allergic reaction (1, 4).
Antigen recognition and uptake by innate immune cells is the
first step in the process of antigen presentation that could lead to
initiation of adaptive immune responses. Using a diverse set of
pattern recognition receptors (PRRs) such as Toll-like receptors
(TLRs) and C-type lectin receptors different types of immune and
non-immune cells are able to sense conserved motifs on antigens.
Dendritic cells (DCs) have been demonstrated to play a pivotal
role in this process; however, the molecular mechanisms of how
Th2-driven allergic immune responses are initiated and amplified
have remained elusive (3–5). Recently, the role of epithelial cells
as key modulators of DC behavior has been highlighted (6, 7).
Specifically, airway epithelial cells (AECs) have been demonstrated
to be able to recognize diverse allergens leading to the release of
chemokines, cytokines, and danger signals that activate and recruit
other immune cells to the site of inflammation (6, 7).
In this review, we will discuss the role of dendritic and epithelial
cells in allergen recognition and how the cross-talk between DCs
and AEC could affect Th2-mediated allergic diseases.
ALLERGEN RECOGNITION BY DENDRITIC CELLS
Immature DCs reside in the peripheral tissues and can efficiently
sample the microenvironment for antigens. Once taken up by
DCs such antigens are processed into peptides and appear on the
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surface of DCs in the context of MHC molecules. Antigen bearing
DC migrate to the local lymph nodes where through expression
of MHCII-peptide complex, cytokines, and co-stimulatory mole-
cules they can stimulate naïve T cells toward distinct effector T cell
subsets (e.g., Th1, Th2, Th17) (8, 9) or induce tolerance through
induction of regulatory T cells (10), depending on the nature
of the antigen and other microenvironmental factors (11). DCs
serve as sentinels of the mucosal surfaces, where they constantly
sample antigens at the interface between external and internal
environments using different PRRs (Figure 1). Even intraepithelial
DCs are able to form tight junctions with epithelial cells through
expression of proteins like occludin and claudin, which can further
facilitate antigen/allergen recognition and uptake by these cells (7,
8). In addition, some allergens can gain access to DCs by disrupt-
ing the tight junctions (9–15); different mechanisms of allergen
recognition and uptake by DCs will be further described in the
following sections.
C-TYPE LECTIN RECEPTORS
C-type lectin receptors are mainly involved in the recognition of
glyco-allergens. Diverse C-type lectin receptors (CLRs), such as
dendritic cell-specific intracellular adhesion molecule 3-grabbing
non-integrin (DC-SIGN) and mannose receptor (MR) on human
DCs have been shown to be able to recognize and internalize
allergens.
MANNOSE RECEPTOR
This type-I integral transmembrane protein is primarily expressed
by myeloid cells such as macrophages and DCs (4, 16). The extra-
cellular portion of MR consists of three regions: a cysteine-rich
domain, a fibronectin type II-like domain, and eight carbohydrate
recognition domains (CRDs). Interestingly, DCs from patients
with house dust mite (HDM) allergy have been shown to express
higher levels of MR and to be more efficient in allergen uptake
than DCs from non-atopic donors (17). More recently, it was
reported that bronchoalveolar lavage fluid from patients with
asthma and/or allergic rhinitis contains higher numbers of MR
expressing myeloid-DCs compared to healthy controls (18). In
terms of allergen uptake, in vitro studies have found that MR
expressed on human monocyte-derived DCs is the main receptor
for major allergens from HDM (Der p 1), dog (Can f 1), cockroach
(Bla g 2), peanut (Ara h 1), and cat (Fel d 1) (19, 20). Similar
studies have also highlighted MR’s role in allergen-induced Th2
cell differentiation where MR-deficient (MR−), as opposed to MR
expressing (MR+), DCs failed to induce Th2 cell differentiation
in response to Der p 1 in DC-T cell co-cultures from HDM atopic
individuals. The bias toward Th1 cell polarization by MR− DCs
was shown to be partially mediated through the up-regulation of
indoleamine 2,3-dioxygenase (IDO) activity in DCs (19). IDO
is an enzyme that participates in tryptophan metabolism and
is involved in many immune-regulatory processes in health and
FIGURE 1 | Receptors involved in allergen recognition and uptake by DCs.
MR can recognize allergens from diverse sources leading to Th2 polarization
and IDO down-regulation in DCs involving a possible cross-talk with TLR4 (19).
TLR4 itself can be activated by airborne allergens and diverse metals in an
MD2 dependent or independent way (33, 35–37). FcεR facilitate allergen
uptake through the recognition of the IgE-allergen complex (41, 46). DC-SIGN
can recognize diverse allergens as well, however, leading to a Th1 polarization.
Finally, TLR5 can be activated by HDM extracts containing flagellin (34).
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disease (21, 22). Further studies by the same group showed that
MR recognition of major cat allergen Fel d 1 mediated the produc-
tion of specific IgE and IgG1 antibodies in a mouse model of allergy
(20). Other studies have shown that omega-1, a glycosylated T2
ribonuclease secreted by Schistosoma mansoni eggs, is recognized
and internalized by DCs through MR and subsequently interferes
with proteins synthesis and conditions DCs for Th2 priming (23).
Collectively these data highlight MR’s role in allergen recognition
and promotion of Th2-mediated immune responses.
DENDRITIC CELL-SPECIFIC INTRACELLULAR ADHESION MOLECULE
3-GRABBING NON-INTEGRIN
Dendritic cell-specific intracellular adhesion molecule 3-grabbing
non-integrin is a type-II integral transmembrane protein that con-
sists of four regions: a CRD, a hinge domain, and a transmembrane
region connected to a cytoplasmic signaling domain (4, 24). DC-
SIGN is mainly expressed by antigen presenting cells (APCs) and
has been demonstrated to participate in the recognition of aller-
gens from different sources, such as peanut, HDM, pollen, and dog
(25–27). In vitro studies have been shown that DC-SIGN recog-
nition and uptake of Der p 1 induces Th1 cell differentiation. On
the contrary, DC-SIGN deficient DCs bias the response toward a
Th2 profile (27). This is opposite to previous observations in MR−
DCs which seem to support Th1 differentiation (19). Interestingly,
it has also been shown that Der p 1, using its enzymatic activity,
can cleave (28) and induce the down-regulation (29) of cell sur-
face DC-SIGN but not MR (28). In this context, we have previously
proposed that the Th1/Th2 balance in response to allergen expo-
sure can be determined by the cross-talk between these receptors
and the level of their expression on DCs (4, 27). Accordingly, it is
important to note that DCs from asthmatic patients show lower
expression of DC-SIGN (29), which is in contrast to the high levels
of MR expression reported in atopic individuals (17, 18).
TOLL-LIKE RECEPTORS
The TLRs are type-I integral membrane receptors, each with an
N-terminal ligand recognition domain constructed of tandem
copies of a leucine-rich repeat motif, a single transmembrane helix,
which participates in nucleic acid pathogen-associated molecular
patterns (PAMPs) recognition, and a C-terminal cytoplasmic sig-
naling domain known as Toll IL-1 receptor domain (30). There
are more than 10 different TLRs identified in humans so far (31),
with some of them being involved in allergen recognition or path-
ways that induces allergic responses. Within this context, mainly
three different mechanisms have been proposed. Der p 2, a major
allergen from HDM with lipid-binding activity, has been shown
to induce signaling through TLR2 (32) and TLR4 (33) depending
on the cell type involved. Due to its high homology with MD2,
which participates in the recognition of lipopolysaccharide (LPS)
by TLR4, Der p 2 forms a complex with TLR4 that signals simi-
larly to MD2/TLR4 complex inducing innate immune activation
(33). In addition, HDM extracts contaminated with flagellin can
induce TLR5-dependent allergic responses in mice, however, the
mechanism is still unclear (34). The second mechanism involves
sensitization by nickel, which may not be relevant in the context of
airway sensitization but highlights the importance of TLR4 on DCs
in allergic reactions. Nickel and other bivalent metals such as cobalt
induce a lipid-independent activation of TLR4, which is depen-
dent on the presence of two histidine residues, promoting TLR4
dimerization and subsequent receptor activation independently of
MD2 (35, 36). Finally, the last mechanism involves allergens such
as Fel d 1 and Can f 6 that belong to lipocalin family and cause
enhanced LPS-induced TLR4 activation in an MD2 dependent and
independent manner respectively (37).
HIGH-AFFINITY IGE RECEPTOR
FcεRI is a multimeric cell surface receptor that binds IgE with
high-affinity. In humans, this receptor can be expressed by mast
cells, basophils, eosinophils, platelets, monocytes, and DCs; how-
ever, in the last four cell types it adopts a trimeric (αγ2) structure
instead of the classical tetrameric (αβγ2) structure (38–43). It
has been previously suggested that cell-bound IgE participates in
the presentation of aero-allergens by Langerhans cells (44). In
addition, the presence of FcεRI on Langerhans cells maximizes
antigen uptake via specific IgE and subsequent presentation to
T cells (45). In monocytes and peripheral blood DCs, FcεRI has
been shown to mediate IgE-dependent allergen presentation (41,
46). Further studies in DCs demonstrated that multimeric ligands
of FcεRI are delivered into a major histocompatibility complex
class II compartment in a Cathepsin S-dependent pathway (47).
In vivo experiments with a transgenic mouse model with human-
like FcεRI expression in DCs showed that after allergen capture
DCs instructed naïve T cells to differentiate into allergen-specific
Th2 cells at the site of allergen exposure (48). Taking into account
the fact that higher expression of FcεRI has been detected in atopic
individuals (40, 42), this can lower the atopic individual’s thresh-
old to mount allergen-specific T cell responses. All this highlights
the fact that the high-affinity IgE receptor could play an important
role in capturing allergens by DCs and subsequent presentation to
T cell particularly in previously sensitized individuals with high
levels of specific IgE; however, the precise role of IgE receptors and
the role of other stimulatory and inhibitory Fc receptors (49, 50)
in allergen presentation still need to be fully understood.
ALLERGEN RECOGNITION BY EPITHELIAL CELLS
Airway epithelial cells constitute the first line of defense against
pathogens and allergens by not only forming a physical barrier,
but also through expressing a wide range of PRR, such as TLRs,
CLRs, and protease activated receptor (PARs) (Figure 2). These
receptors enable AECs to recognize microbial motifs and environ-
mental allergens which lead to a cascade of events culminating
in the release of cytokines, chemokine ligands, and danger signals
which recruit and activate other immune cells.
PROTEASE ACTIVATED RECEPTORS
Protease activated receptors are G-protein coupled receptors char-
acterized by a self-activation mechanism following proteolytic
cleavage of their extracellular N-terminal domain. There are four
PAR members identified to date. PAR-1,-3,-4 respond to the pro-
tease thrombin, expressed primarily by cells in the vasculature;
and are mainly involved in homeostasis and thrombosis. Con-
versely, PAR-2 is activated by trypsin-like serine proteases but not
by trypsin and can be found in airways, vascular, skin, and intesti-
nal cells, and mediates proliferative and inflammatory responses
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FIGURE 2 | Receptors involved in allergen recognition and uptake by
AECs. TLR4 can be activated by pollen allergens and activate TSLP-OX40L
signaling pathway (88). PAR-2 is activated by different allergens from HDM,
cockroach, and fungus inducing the production of cytokines and chemokines
that modulate DC behavior (60, 61, 64–67). Dectin-1 is able to recognize
allergens from HDM and induce the secretion of CCL20 (90). In addition, the
secretion of TSLP induced by Der p 1 in AECs is thought to be
carbohydrate-dependent, however, no receptor has been identified (92).
linked to tissue damage (51, 52). In addition, endothelial cells,
epithelial cells, fibroblasts, and immune cells such as lymphocytes,
monocytes, mast cells, neutrophils, eosinophils, macrophages, and
DCs have been shown to express functional PAR-2 (53, 54). Due to
its ability to respond to serine proteases, proteolytic allergens from
diverse sources such as HDM, cockroach, pollen, or mold can act
as exogenous activators of PAR-2 with implications in allergy and
asthma.
Different cysteine and serine proteases from HDM, pollen, and
the fungus Penicillium have been shown to increase epithelial
permeability and disrupt the tight junctions by mainly target-
ing the transmembrane adhesion proteins occludin and zonula
occludens-1 (9–15). In addition, it has been demonstrated that
allergen-induced cytokine production, cell detachment and mor-
phological changes in AECs is largely dependent on allergens’
protease activity (13, 55–58). Protease-dependant induction of IL-
25 and thymic stromal lymphopoietin (TSLP) have been shown to
be mediated by Erk and p38 MAPK pathways (58). More recently, it
was demonstrated, in an in vivo model, that IL-33 also contributes
to protease-dependent allergic airway inflammation (59).
Main allergens from HDM can activate PAR-2 and induce the
release of pro-inflammatory cytokines (60, 61). However, there is
some contradictory results showing that Der p 1-induction of IL-
8 and IL-6 is independent of PAR-2 activation and dependent on
nuclear factor κB (NF-κB) and Erk signaling pathways (62, 63). In
the case of allergens from the German cockroach and the fungus
Penicillium, this effect has been demonstrated to be mediated by
the activation of Erk (64, 65). In an in vivo model of allergy, only
when the allergens are administered through the mucosa, cock-
roach proteases regulate chemokine production and DC recruit-
ment in a PAR-2-dependent way (66, 67). Furthermore, it was
demonstrated that cockroach proteases augmented tumor necrosis
factor (TNF)-α-induction of the matrix metalloproteinases-9, an
enzyme that has been implicated in the pathogenesis of bronchial
asthma (68,69),by a mechanism linking PAR-2,Erk,and AP-1 acti-
vation (70). More recently, PAR-2-mediated allergic sensitization
was shown to be associated with TNF signaling pathways (71).
In addition to the proteolytic activity of some allergens, one of
the main soluble mediators that accounts for the increase in epithe-
lial permeability is the vascular endothelial growth factor (VEGF).
It has been shown that extract from cockroach increases bronchial
airway epithelial permeability by inducing the release of VEGF
(72). Besides, HDM extract can induce the secretion of VEGF by
human pulmonary epithelial cells (73). Recently, it was demon-
strated that HDM-induced redistribution of E-cadherin was medi-
ated via epidermal growth factor receptor-dependent activation of
PAR-2 and transforming growth factor-β (TGF-β) enhanced this
signaling (74). Nevertheless, not only PAR-2 is directly involved
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in allergen-mediated cytokine production, it has also been shown
that IL-8 production by AECs in response to allergens from the
fungus Penicillium is dependent on PAR-1 and PAR-2 via activa-
tion of ERK1/2 (65). In addition, proteases from different fungal
allergens induce the release of pro-inflammatory cytokines from
human nasal polyp epithelial cells, leading to eosinophil and neu-
trophil migration, in a mechanism that could involve PAR-2 and
PAR-3 (75).
TOLL-LIKE RECEPTOR-4
As previously described, TLRs are widely expressed by both APCs
and epithelial cells and recognize conserved microbial structures
and as such play a key role in controlling adaptive immune
responses. LPS is recognized by TLR4 with the participation of
the accessory proteins including CD14, LPS binding protein, and
MD2. This leads to the recruitment of the signaling adapter pro-
tein MyD88, the activation of the transcription NF-κB among
others, and the expression of pro-inflammatory cytokines (76).
TLR4 (77–80), MyD88 (79, 81, 82), and NF-κB (83–86) have been
shown to be crucial in the elicitation of allergic Th2 immune
responses. Different studies using knock-out mice have demon-
strated the importance of TLR4 expression in both hematopoietic
radiosensitive and structural radioresistant cells in the induction
of TLR4-dependent Th2 responses to intranasal allergens in the
presence of endotoxin (77–80). In addition, it has been shown that
the LPS dosage is crucial in driving either Th1 or Th2 responses,
with lower levels of LPS inducing Th2 responses to inhaled aller-
gens in a mouse model of allergic sensitization (87). Recently, it
was shown that short ragweed pollen acts as a TLR4 agonist, initi-
ating TLR4-dependet TSLP/OX40L signaling pathway, triggering
Th2 allergic inflammation (88).
C-TYPE LECTIN RECEPTORS
C-Type Lectin Receptors are receptors that recognize oligosac-
charide moieties among other molecular patterns on antigens
including allergens (89). CLR’s role in allergen recognition and
uptake by DCs is well established (4); moreover, they have also
been shown to participate in allergen recognition by AECs. It
was demonstrated that HDM induction of CCL20 by AECs was
not protease or TLR4/2 dependant; however, it was mediated by
β-glycan moieties within HDM extract. This effect was specific
for HDM because other allergens, such as cockroach and rag-
weed, failed to induce this response (90). The authors suggest the
involvement of the dectin-1/Syk signaling pathway, since Syk inhi-
bition abrogated the HDM-induced CCL20 production (91). More
recently, our group demonstrated that TSLP secretion by AECs
upon stimulation with Der p 1 was at least partly carbohydrate-
dependent. In addition, DC uptake of deglycosylated Der p 1
was considerably decreased compared with its natural (glycosy-
lated) counterpart, indicating that glycosylation of allergens plays
a crucial role in their recognition by immune and non-immune
cells (92).
CROSS-TALK BETWEEN DENDRITIC AND EPITHELIAL CELLS
Due to their strategic location at the interface of external-internal
environments, AECs are able to modulate and coordinate immune
responses. Ample data have shown that the cross-talk between DCs
and AECs is crucial in driving allergen-induced Th2 responses (6,
7). As previously described, the ligation of different PRR on AECs
results in the secretion of chemokines (93–95), that attract DCs,
and cytokines that induce DC maturation and activation. How-
ever, there are some contradictory results indicating that inducible
signals driven by LPS in non-hematopoietic tissues such as AECs
do not play an essential role in DCs activation (96). On the other
hand other studies have demonstrated that AECs can induce DC
maturation after LPS inhalation (81). Nevertheless a range of
cytokines including TSLP, IL-33, IL-25, IL-1β, and granulocyte
macrophage colony-stimulating factor (GM-CSF) are known to
be secreted by AECs after allergen challenge (6, 7) which are able
to modulate DCs function (Figure 3). Here we focus on TSLP as a
key cytokine in initiation and maintenance of allergic responses.
ROLE OF TSLP
Thymic stromal lymphopoietin is a 140-amino acid four-helix-
bundle cytokine that belongs to the IL-2 family of cytokines. This
cytokine is mainly produced by AECs and is able to modulate
DC by binding to its receptor complex composed by the TSLP
receptor (TSLPR) and the IL-7 receptor (IL-7R) (97). This induces
the production of Th2-attracting chemokines such as CCL22 and
CCL17, and primes naïve T cells to produce IL-5, IL-4, TNF-α,
IL-13, whereas down-regulate IL-10 and IFN-γ (98, 99) even in
the absence of DCs in an IL-4 dependant way (100). TSLP induces
the expression of OX40L in DCs which in turn has been shown to
trigger Th2 cell polarization in the absence of IL-12 (101). Con-
versely, TSLP is also able to induce IL-12 secretion after CD40
ligation in DCs however still maintaining its Th2-polarizing effect
(102). Furthermore, DCs activated with TSLP were able to induce
the expansion of Th2 memory cells and help to maintain their
phenotype (103).
Human epithelial cells can produce TSLP in response to diverse
stimuli, such as microbial products, physical injury, ambient par-
ticulate matter, protease allergens, and either pro-inflammatory or
Th2-polarizing cytokines (58, 104–108). Protease allergens induce
TSLP in a PAR-2-dependent way (109) with the involving of
MAPK signaling pathway (58) however inflammatory cytokines
induction of TSLP is NF-κB signaling dependent (104, 106). In
addition to DCs, TSLP can also activate mast cells and CD34+
blood hematopoietic progenitor cells to produce Th2 cytokines
and in that way induce the innate phase of allergic immune
responses (105, 110). Finally, TSLP can interfere with regula-
tory T cell development impairing the balance between tolerance
and inflammation (111). Keratinocytes too can secrete functional
TSLP after stimulation with pro-inflammatory or Th2-driven
cytokines, and induces DC activation in human skin lesions of
atopic dermatitis (112). Recently, it was demonstrated that DCs
can also produce TSLP in response to TLR stimulation. Moreover,
interestingly DCs from mice challenged with HDM extract express
higher mRNA levels of TSLP than epithelial cells (113).
In vivo experiments have shown that TSLPR knock-out mice
exhibited strong Th1 responses while Th2 responses were impaired
and they failed to develop an inflammatory response to allergen
challenge to lung (114) or skin (115). In addition, skin and lung
over-expression of TSLP induces atopic dermatitis (116) and air-
way inflammation respectively (117). In an experimental model of
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FIGURE 3 | Role of AECs in allergen sensitization. AECs can directly
recognize allergens by PARs, TLRs or CLRs, and through NF-κB
signaling, they induce the production of the cytokines (TSLP, GM-CSF,
IL-33, IL-25, IL-1β), chemokine ligands (CCL2, CCL20), and danger
signals (adenosine triphosphate, uric acid). TSLP has diverse effects on
DCs and mast cells, which in absence of the cytokine IL-12 can lead to
recruitment of Th2 cells and (eosinophils, Th2 polarization, and the
onset of allergy or allergic asthma. Moreover, IL-25 can activate Th2
cells to produce pro-allergenic cytokines. On the other hand, DCs are
able to form tight junction with AECs, and allergen can digest the tight
junction and both phenomena contribute to facilitate the allergen
sensitization process (6, 7).
allergic conjunctivitis it was demonstrated that after topical aller-
gen challenge mucosal epithelial cells produce high levels of TSLP
compared with controls leading to induction of allergic inflam-
mation through the TSLP-OX40L signaling pathway (118). More
recently, it was shown that the soluble TSLPS antagonist, com-
prised of the extracellular domain of the murine TSLPR and an
IgG2a Fc tail, reduced the severity of airway inflammation by
regulating DC function (119).
Furthermore, it has been demonstrated that TSLP and
Th2-attracting chemokines are increased in airways of asth-
matic subjects compared with normal controls (120). In addi-
tion, different studies have shown an association between
genetic polymorphisms in the human IL-7Rα chain and TSLP
genes with allergy, allergic rhinitis, and bronchial asthma fur-
ther highlighting a possible link between these proteins and
allergy (121–123).
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CONCLUSION
Dendritic cells are professional APCs and sentinels of the immune
system that efficiently sample allergens in the airways leading to a
cascade of events that culminates in the induction of Th2 type
immune responses. DCs are able to recognize and internalize
allergens from diverse sources through expression of a plethora
of receptors such as CLRs, TLRs, and FcεR. Recently, the role of
AECs as key players in the modulation and induction of DCs in
the airways has been highlighted. Like DCs, AECs are able to rec-
ognize allergens through several PRRs including PARs, CLRs, and
TLRs. This further leads to the production of different cytokines,
chemokines, and danger signals with the ability to initiate and
propagate immune responses to allergens. Allergens have diverse
molecular features such as specific oligosaccharide moieties, pro-
tease activity, lipid-binding properties, among others that can
facilitate their recognition by immune and non-immune cells and
contributes to their “allergenicity.” Better understanding of the
molecular basis of early events at the interface of allergens and
their receptors and the key soluble mediators/signaling pathways
involved could lead to development of more effective therapeu-
tic strategies for allergic diseases including allergic asthma. For
instance, due to the contribution of TLRs and CLRs in the recogni-
tion of allergen by both DCs and AECs, agonist and antagonists to
those receptors may provide new therapeutic targets to modulate
allergic responses. In addition, different studies have highlighted
the role of sugar moieties on allergens in their recognition and
internalization by immune cells. Accordingly, different “glyco-
forms” of allergens with immunoregulatory properties could be
developed and used in allergen-specific immunotherapy strate-
gies. Finally, diverse intracellular and extracellular molecules have
been implicated in the process of allergen recognition and sen-
sitization. Further studies to decipher these mechanisms could
pave the way for the rational design of more effective therapeutic
entities for the treatment of allergic diseases.
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